Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias: Complete Statistical AnalysisIndependent statistical analysis of Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias: primary endpoint results, effect estimate with confidence interval,…
- Open-Label, Bridging Study of Telaprevir in Treatment-Naïve and Treatment-Experienced Russian Patients With Genotype 1 Chronic Hepatitis C: Complete Statistical AnalysisIndependent statistical analysis of Open-Label, Bridging Study of Telaprevir in Treatment-Naïve and Treatment-Experienced Russian Patients With Genotype 1 Chronic Hepatitis C: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies – (FIGHT-101): Complete Statistical AnalysisIndependent statistical analysis of Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Open-Label, Multiple-Dose, Non-Randomized Study to Assess Drug-Drug Interactions of Proellex® in Female Subjects: Complete Statistical AnalysisIndependent statistical analysis of Open-Label, Multiple-Dose, Non-Randomized Study to Assess Drug-Drug Interactions of Proellex® in Female Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Open-label, Phase II Study of MLN9708 in Patients With Relapsed/Refractory Cutaneous and Peripheral T-cell Lymphomas: Complete Statistical AnalysisIndependent statistical analysis of Open-label, Phase II Study of MLN9708 in Patients With Relapsed/Refractory Cutaneous and Peripheral T-cell Lymphomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Open-label, Randomized Study in a Pediatric Population in a JEV (Japanese Encephalitis Virus)-Endemic Country: Complete Statistical AnalysisIndependent statistical analysis of Open-label, Randomized Study in a Pediatric Population in a JEV (Japanese Encephalitis Virus)-Endemic Country: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU.: Complete Statistical AnalysisIndependent statistical analysis of Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU.: primary endpoint results, effect…
- Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Participants With Attention-deficit Hyperactivity Disorder (ADHD): Complete Statistical AnalysisIndependent statistical analysis of Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Participants With Attention-deficit Hyperactivity Disorder (ADHD): primary endpoint results, effect estimate with confidence interval, sample-size…
- Open-Labeled PK-PD Studies of Metoprolol ER: Complete Statistical AnalysisIndependent statistical analysis of Open-Labeled PK-PD Studies of Metoprolol ER: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02417246).
- Open, Prosp, Rand. Invest. Evaluating Pain With Mepitel One vs.Bridal Veil and Staples on Split Thickness Skin Grafts: Complete Statistical AnalysisIndependent statistical analysis of Open, Prosp, Rand. Invest. Evaluating Pain With Mepitel One vs.Bridal Veil and Staples on Split Thickness Skin Grafts: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- OpenDoorIndependent statistical analysis of Increasing Use of Mental Health Services: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00605358).
- OPERAIndependent statistical analysis of A Study of the Safety and Immunogenicity of Repeated rhC1INH Administration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- OPERAIndependent statistical analysis of Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00970489).
- OPERA IIIndependent statistical analysis of A Study To Monitor Long-Term Treatment With PF-00547659: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01298492).
- Operative vs Non-Operative Management of Acute Appendicitis and Acute Cholecystitis in COVID-19 Positive Patients: Complete Statistical AnalysisIndependent statistical analysis of Operative vs Non-Operative Management of Acute Appendicitis and Acute Cholecystitis in COVID-19 Positive Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Operetta 2Independent statistical analysis of A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS): primary endpoint results, effect estimate with…
- OPESIIndependent statistical analysis of Orthodontic Patient Experience of Intraoral Scans Versus Alginate Impressions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05194956).
- Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson’s Disease (PD) Patients: Complete Statistical AnalysisIndependent statistical analysis of Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Opiates Prescribing for Knee Arthroscopies and ACL Reconstruction: Complete Statistical AnalysisIndependent statistical analysis of Opiates Prescribing for Knee Arthroscopies and ACL Reconstruction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03876743).
- Opioid Consumption and Disposal After Shoulder Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Opioid Consumption and Disposal After Shoulder Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05525975).
- Opioid Free and Therapy Minimized Advantages Using HANA Table for Total Hip Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Opioid Free and Therapy Minimized Advantages Using HANA Table for Total Hip Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Opioid Taper Study: Complete Statistical AnalysisIndependent statistical analysis of Opioid Taper Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03912298).
- Opioid Treatment for Chronic Low Back Pain and the Impact of Mood Symptoms: Complete Statistical AnalysisIndependent statistical analysis of Opioid Treatment for Chronic Low Back Pain and the Impact of Mood Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Opioid Use Disorder in the Emergency Department: CTN 0069: Complete Statistical AnalysisIndependent statistical analysis of Opioid Use Disorder in the Emergency Department: CTN 0069: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03023930).
- Opioid-Free Anesthetic for Tonsillectomy: Complete Statistical AnalysisIndependent statistical analysis of Opioid-Free Anesthetic for Tonsillectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04528173).
- Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL): Complete Statistical AnalysisIndependent statistical analysis of Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01298219).
- OPSENSIndependent statistical analysis of The Drift-Reduction for Improved FFR Using Fiberoptic Technology (DRIFT) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03848650).
- OPSISIndependent statistical analysis of Study Assessing the Efficacy and Safety of STN1013600 Ophthalmic Solution 0.1% and 0.3% Compared With Placebo in Subjects With Presbyopia: primary endpoint results, effect estimate with confidence interval,…
- OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission: Complete Statistical AnalysisIndependent statistical analysis of OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission: primary endpoint results,…
- Opt-INIndependent statistical analysis of Opt-IN: Optimization of Remotely Delivered Intensive Lifestyle Treatment for Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01814072).
- OPT101 in Type 1 Diabetes Patients: Complete Statistical AnalysisIndependent statistical analysis of OPT101 in Type 1 Diabetes Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05428943).
- OpT2miseIndependent statistical analysis of OpT2mise Glucose Control in Type 2 Diabetes Mellitus (DM) With Insulin Pump Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Optic Nerve Head Structural Response to IOP Elevation in Patients With Keratoconus: Complete Statistical AnalysisIndependent statistical analysis of Optic Nerve Head Structural Response to IOP Elevation in Patients With Keratoconus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Optic-to-Audio Device in a Pediatric Cohort With CLN3-related Conditions or Low Vision: Complete Statistical AnalysisIndependent statistical analysis of Optic-to-Audio Device in a Pediatric Cohort With CLN3-related Conditions or Low Vision: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Optical Frequency Domain Imaging (OFDI) Surveillance and Image Guided Biopsy of the Esophagus: Complete Statistical AnalysisIndependent statistical analysis of Optical Frequency Domain Imaging (OFDI) Surveillance and Image Guided Biopsy of the Esophagus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Optiflow THRIVE for Delivery of Oxygen to Patients During Total Intravenous Anesthesia While Undergoing Radiology Procedures: Complete Statistical AnalysisIndependent statistical analysis of Optiflow THRIVE for Delivery of Oxygen to Patients During Total Intravenous Anesthesia While Undergoing Radiology Procedures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- OPTIMALIndependent statistical analysis of Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size…
- OPTIMALIndependent statistical analysis of Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Optimal Bupivacaine Dose for Initiation of Labor Epidural Techniques: Complete Statistical AnalysisIndependent statistical analysis of Optimal Bupivacaine Dose for Initiation of Labor Epidural Techniques: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04814537).
- Optimal Care of Complicated Appendicitis: Complete Statistical AnalysisIndependent statistical analysis of Optimal Care of Complicated Appendicitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03159754).
- Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in Uganda: Complete Statistical AnalysisIndependent statistical analysis of Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in Uganda: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Optimal Dose of Prophylactic Naloxone in Reducing Opioid-Induced Side Effects in Children/Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Optimal Dose of Prophylactic Naloxone in Reducing Opioid-Induced Side Effects in Children/Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Optimal Dosing of Ketamine for Procedural Sedation and Analgesia in Children: Complete Statistical AnalysisIndependent statistical analysis of Optimal Dosing of Ketamine for Procedural Sedation and Analgesia in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Optimal Duration of Indwelling Urinary Catheter Following Pelvic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Optimal Duration of Indwelling Urinary Catheter Following Pelvic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01923129).
- Optimal Fluid Resuscitation for Trauma Patients: Complete Statistical AnalysisIndependent statistical analysis of Optimal Fluid Resuscitation for Trauma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00527098).
- Optimal Location of Nerve Block to Minimize Perioperative Opioid Administration in ACL Surgery: Comparing True Adductor Canal to Proximal Block: Complete Statistical AnalysisIndependent statistical analysis of Optimal Location of Nerve Block to Minimize Perioperative Opioid Administration in ACL Surgery: Comparing True Adductor Canal to Proximal Block: primary endpoint results, effect estimate with confidence interval,…
- Optimal Method for Mydriasis in Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of Optimal Method for Mydriasis in Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02909140).
- OPTIMenIndependent statistical analysis of Optimizing Protein Intake in Older Americans With Mobility Limitations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01275365).
- OPTIMEVIndependent statistical analysis of Epidemiology of Thromboembolism Disease: A Cohort Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00670540).